Peptide record

TPDB09819

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09819
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
ITPATPFTPAIITEITAAVIA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C99H163N21O29
RNDCQGHLKMSWY
AIT
2111.51
3.29
0
1
12
-1
-1.00
1.271
130.48
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
5
Residue Composition
number
5
A
0
R
0
N
0
D
0
C
1
E
0
Q
0
G
0
H
5
I
0
L
0
K
0
M
1
F
3
P
0
S
5
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 5 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 5 L: 0 K: 0 M: 0 F: 1 P: 3 S: 0 T: 5 W: 0 Y: 0 V: 1
Chemical Descriptors
21 reviewed residue count
C99H163N21O29 sequence-only estimate (linear, free termini)
2111.51 sequence-only estimate (linear, free termini)
3.29 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-1.00 sequence-only estimate (linear, free termini)
1.271 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.06 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against S. aureus (MIC 0.06 ug/ml), MRSA (MIC 0.96 ug/ml), and VISA (MIC 3.82 ug/ml) (provided by Chunfeng Wang).
Evidence 2 Activity

Activity

MIC
Antifungal
0.06 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against S. aureus (MIC 0.06 ug/ml), MRSA (MIC 0.96 ug/ml), and VISA (MIC 3.82 ug/ml) (provided by Chunfeng Wang).
Evidence 3 Activity

Activity

MIC
Antiparasitic
0.06 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against S. aureus (MIC 0.06 ug/ml), MRSA (MIC 0.96 ug/ml), and VISA (MIC 3.82 ug/ml) (provided by Chunfeng Wang).
Evidence 4 Activity

Activity

MIC
Antiviral
0.06 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against S. aureus (MIC 0.06 ug/ml), MRSA (MIC 0.96 ug/ml), and VISA (MIC 3.82 ug/ml) (provided by Chunfeng Wang).